Navigation Links
BCC Research Publishes a New Report On Global Markets for Surveillance and Monitoring of Explosive, Chemical, Biological, and Nuclear (Ecbn) Hazards.

Wellesley, MA (PRWEB) August 18, 2013

According to a new technical market research report, SURVEILLANCE AND MONITORING OF EXPLOSIVE, CHEMICAL, BIOLOGICAL AND NUCLEAR HAZARDS (SAS005D), from BCC Research (, the market for surveillance and monitoring of ECBN (Explosive, Chemical, Biological, and Nuclear) hazards was valued at $148.3 billion in 2012 and is expected to reach $169.5 billion in 2013. The report forecasts total market value to surpass $387.9 billion in 2019, after increasing at a five-year compound annual growth rate of 14.9%.

The demand for radiation/nuclear hazard monitoring equipment increased dramatically after the Chernobyl disaster in Russia in 1986. The industry for monitoring these hazards continued to grow after a number of significant global hazard events. Some of the major events that impacted the growth of the industry include the terrorist acts of September 11, 2001 and the earthquake and tsunami-induced disaster at the Fukushima nuclear power plant in Japan in 2011.

The employment or threat of explosives, chemical, biological, radiological, and nuclear weapons including toxic industrial materials presents serious challenges to peaceful countries worldwide. The deadly, destructive, and disruptive effects of these weapons and materials demand continuous vigilance by all concerned, and every country must train for and remain prepared to face the threat they pose.

BCC Research’s new report shows how the past few years have seen enormous advances in exciting and promising new technologies designed to detect and monitor ECBN hazards and to protect the personnel who must deal with them. The ECBN industry is characterized by equipment production that is moving steadily towards one size fits all and combination equipment that can detect a growing number of substances in the ECBN hazard spectrum.

BCC Research in its published report has completed an in-depth analysis of the three major sectors in this report: ECBN hazard monitoring, decontamination, and personal protective equipment. The largest and fastest growing of these segments is ECBN hazard monitoring. This segment’s size and growth is linked to significant global events.

In addition to these global events, BCC Research has identified a number of forces driving the growth of the ECBN hazard surveillance and monitoring market. These market influencers include the rise in public and private funding outlay for research and development, improving technology and function, government legislation of areas such as airports, embassies, oil fields and nuclear power plants. Additionally, the government is also encouraging the demand for hazard protection by implementing biometric markers in passport.

This new report from BCC Research is intended to serve as a valuable resource for all personnel involved in the production and marketing of various types of monitoring equipment, researchers working in the development of new technologies for monitoring various ECBN hazards, and for manufacturers of different types of sensors used in monitoring equipment. The report will also find favor with military strategists and civil defense planners who prepare for eventualities caused by ECBN hazards.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. UCLA Brain Injury Research Center gets NCAA funding for research on sports concussions
2. NIH awards $20 million over 5 years to train next generation of global health researchers
3. Researchers develop a new cell and animal model of inflammatory breast cancer
4. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
5. Sexually abused boys at risk for more unsafe sex: UBC research
6. Researchers Find Gene Mutations That May Be a Key to Autism
7. LSUHSC research finds HPV-related head & neck cancers rising, highest in middle-aged white men
8. Researchers find evidence of banned antibiotics in poultry products
9. Presidential keynote address and new research highlights from the American Society of Pediatric Otolaryngology meeting
10. Scientific session and new research highlights
11. NJ stroke researchers report advances in spatial neglect research at AAN Conference
Post Your Comments:
(Date:12/1/2015)... ... 2015 , ... Trustify is proud to announce the success of the seventh ... organization dedicated to ending domestic violence. , Trustify and Becky’s Fund have joined forces ... of domestic violence. Trustify is also proud to announce the launch of the company’s ...
(Date:12/1/2015)... ... December 01, 2015 , ... Henderson, ... Tennessee to receive Gigabit Internet through a partnership this year with Aeneas Internet ... Henderson is an attractive destination for entrepreneurs who want to build a business. ...
(Date:12/1/2015)... ... December 01, 2015 , ... According to an ... has filed a discrimination claim against the U.S. Department of Health and Human Services, ... Care Act (ACA) plans are breaking the clause in the law prohibiting the denial ...
(Date:12/1/2015)... ... December 01, 2015 , ... Speech and ... believe that with innovative technologies and under the right circumstances, these practices can ... benefit of a dual-approach to his or her therapeutic sessions, as well as ...
(Date:12/1/2015)... ... 2015 , ... It’s official: Tattoo taboo is a thing of the past. ... Millennials (a whopping one in three aged 18 to 25 is inked). As tattoos ... their ink. In fact, RealSelf , the world’s largest community for learning and ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 1, 2015 Contraceptives ... Contraceptives, Male Condoms, Female Condoms, Intrauterine Devices, ... Diaphragms, Contraceptive Sponges, Non-Surgical Permanent Contraception Devices) ... Trends and Forecast 2014 - 2020 ", ... (TMR).The report states that the global contraceptives ...
(Date:12/1/2015)... 2015   MabVax Therapeutics Holdings, Inc . (OTCQB: ... has filed an Investigational New Drug Application (IND) with ... Company,s lead fully human antibody product HuMab 5B1 as ... to initiate the Phase I clinical trial early in ... The planned Phase I trial will evaluate the ...
(Date:12/1/2015)... 2015  InCarda Therapeutics, Inc. (InCarda), a privately-held biopharmaceutical ... for cardiovascular conditions via the inhalation route, today announced ... Australia . InCarda is planning to undertake ... in the first half of 2016. The ... in Adelaide and Melbourne.  In ...
Breaking Medicine Technology: